ArticleBMC complementary medicine and therapies2026
Protective effects of Tinospora crispa and Tinospora cordifolia extracts against methylglyoxal-induced oxidative stress and apoptosis in hFOB 1.19 cells: ELISA-based evaluation and molecular docking insights with antioxidant enzymes.
Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundExcessive production of reactive oxygen species (ROS) and advanced glycation end products (AGE) induced by methylglyoxal (MGO) contribute to oxidative stress and cellular apoptosis in osteoblasts, ultimately disrupting bone homeostasis. This study aimed to investigate the protective effects of Tinospora crispa and Tinospora cordifolia extracts against MGO-induced oxidative stress and apoptosis in hFOB 1.19 osteoblastic cells.
methodsMethanolic and aqueous extracts were evaluated for their ability to reduce intracellular ROS, caspase-3 expression, and AGE expression through ELISA based assays. Molecular docking was performed between selected bioactive compounds of these extracts and related proteins through AutoDock Vina. Statistical analyses were performed using ANOVA, followed by post-hoc tests.
resultsMethanolic extracts of T. crispa (240 µg/mL) and T. cordifolia (100 µg/mL) significantly reduced intracellular ROS levels by 46.8% and 41.2%, respectively (p < 0.05). Caspase-3 expression in MGO-induced osteoblast cells was significantly decreased following treatment with T. crispa and T. cordifolia extracts, indicating anti-apoptotic effects. However, only methanolic T. cordifolia (100 µg/mL) and aqueous T. crispa at (375 µg/mL) significantly reduced intracellular AGE expression (p < 0.05), suggesting selective effects on oxidative stress pathways. Molecular docking analysis revealed strong binding affinities of key bioactive compounds particularly towards berberine with xanthine oxidase (-8.3 kcal/mol) and caspase-9 (-8.7 kcal/mol). Meanwhile, superoxide dismutase showed a strong binding affinity towards quercetin (-7.9 kcal/mol).
conclusionThese findings suggest that T. crispa and T. cordifolia extracts possess significant antioxidant and anti-apoptotic properties, making them promising therapeutic agents in mitigating MGO-induced osteoblastic damage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.